Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
Health insurance
The Ways & Means markup pushes new transparency, reporting, and oversight rules as hospitals and insurers warn of compliance burdens.
The Federal Trade Commission says the settlement will increase transparency and competition across the entire drug supply chain.
An external audit of the insurers in-home assessment program for Medicare Advantage seniors found nearly all diagnoses made during visits were supported by medical records.
A Peterson-KFF analysis shows ACA premiums climbing in 2027 due to rising medical costs, inflation, higher utilization, and shifts in the marketplace risk pool.
The panel, which typically convenes three times per year to review scientific evidence on preventive screenings and treatments, has not met in person since March 2025.
Compliance, regulatory fairness, and $115m in bonus payments are at the heart of why insurer Elevance Health says it is taking CMS to court.
Two reports examined prior authorization practices at the three largest Medicare Advantage Organizations across acute care, rehabilitation, and nursing facilities.